Literature DB >> 25840008

Neurodegenerative diseases: expanding the prion concept.

Lary C Walker1, Mathias Jucker.   

Abstract

The prion paradigm has emerged as a unifying molecular principle for the pathogenesis of many age-related neurodegenerative diseases. This paradigm holds that a fundamental cause of specific disorders is the misfolding and seeded aggregation of certain proteins. The concept arose from the discovery that devastating brain diseases called spongiform encephalopathies are transmissible to new hosts by agents consisting solely of a misfolded protein, now known as the prion protein. Accordingly, "prion" was defined as a "proteinaceous infectious particle." As the concept has expanded to include other diseases, many of which are not infectious by any conventional definition, the designation of prions as infectious agents has become problematic. We propose to define prions as "proteinaceous nucleating particles" to highlight the molecular action of the agents, lessen unwarranted apprehension about the transmissibility of noninfectious proteopathies, and promote the wider acceptance of this revolutionary paradigm by the biomedical community.

Entities:  

Keywords:  Alzheimer's disease; Parkinson's disease; amyloid; cell-to-cell spreading; disease progression; prion; proteopathy; synuclein; tau; transmission

Mesh:

Substances:

Year:  2015        PMID: 25840008      PMCID: PMC4803040          DOI: 10.1146/annurev-neuro-071714-033828

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  168 in total

1.  Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.

Authors:  K Peter R Nilsson; Andreas Aslund; Ina Berg; Sofie Nyström; Peter Konradsson; Anna Herland; Olle Inganäs; Frantz Stabo-Eeg; Mikael Lindgren; Gunilla T Westermark; Lars Lannfelt; Lars N G Nilsson; Per Hammarström
Journal:  ACS Chem Biol       Date:  2007-08-03       Impact factor: 5.100

2.  Neural pathogenesis of experimental scrapie after intraocular inoculation of hamsters.

Authors:  N Buyukmihci; F Goehring-Harmon; R F Marsh
Journal:  Exp Neurol       Date:  1983-08       Impact factor: 5.330

3.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

Review 4.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

Review 5.  Transmissible spongiform encephalopathies.

Authors:  Steven J Collins; Victoria A Lawson; Colin L Masters
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

6.  Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis.

Authors:  Yvonne S Eisele; Sarah K Fritschi; Tsuyoshi Hamaguchi; Ulrike Obermüller; Petra Füger; Angelos Skodras; Claudia Schäfer; Jörg Odenthal; Mathias Heikenwalder; Matthias Staufenbiel; Mathias Jucker
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

7.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

Review 8.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

9.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

10.  p53 Aggregates penetrate cells and induce the co-aggregation of intracellular p53.

Authors:  Karolyn J Forget; Guillaume Tremblay; Xavier Roucou
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  119 in total

Review 1.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

2.  Expanding the prion disease repertoire.

Authors:  Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-01       Impact factor: 11.205

Review 3.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 4.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

5.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.

Authors:  Yiming Wang; Qing Shao; Carol K Hall
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

Review 7.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

8.  Unfolded and intermediate states of PrP play a key role in the mechanism of action of an antiprion chaperone.

Authors:  Rafayel Petrosyan; Shubhadeep Patra; Negar Rezajooei; Craig R Garen; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

Review 9.  A brief overview of the Swi1 prion-[SWI+].

Authors:  Dustin K Goncharoff; Zhiqiang Du; Liming Li
Journal:  FEMS Yeast Res       Date:  2018-09-01       Impact factor: 2.796

10.  Propagation of prions causing synucleinopathies in cultured cells.

Authors:  Amanda L Woerman; Jan Stöhr; Atsushi Aoyagi; Ryan Rampersaud; Zuzana Krejciova; Joel C Watts; Takao Ohyama; Smita Patel; Kartika Widjaja; Abby Oehler; David W Sanders; Marc I Diamond; William W Seeley; Lefkos T Middleton; Steve M Gentleman; Daniel A Mordes; Thomas C Südhof; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.